PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 176 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $328,000 | -67.3% | 25,833 | 0.0% | 0.00% | -75.0% |
| Q1 2019 | $1,002,000 | +90.5% | 25,833 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $526,000 | -55.6% | 25,833 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $1,184,000 | -22.5% | 25,833 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $1,528,000 | -13.1% | 25,833 | 0.0% | 0.01% | -14.3% |
| Q1 2018 | $1,758,000 | -31.2% | 25,833 | 0.0% | 0.01% | -30.0% |
| Q4 2017 | $2,554,000 | -17.5% | 25,833 | 0.0% | 0.01% | -16.7% |
| Q3 2017 | $3,094,000 | +37.0% | 25,833 | 0.0% | 0.01% | +33.3% |
| Q2 2017 | $2,258,000 | +135.0% | 25,833 | 0.0% | 0.01% | +125.0% |
| Q1 2017 | $961,000 | +21.2% | 25,833 | 0.0% | 0.00% | +33.3% |
| Q4 2016 | $793,000 | -54.2% | 25,833 | 0.0% | 0.00% | -57.1% |
| Q3 2016 | $1,732,000 | +124.9% | 25,833 | 0.0% | 0.01% | +133.3% |
| Q2 2016 | $770,000 | +1.4% | 25,833 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $759,000 | -81.3% | 25,833 | -50.0% | 0.00% | -66.7% |
| Q4 2015 | $4,050,000 | +108.0% | 51,666 | +100.0% | 0.01% | +12.5% |
| Q3 2015 | $1,947,000 | +53.9% | 25,833 | +138.5% | 0.01% | +60.0% |
| Q2 2015 | $1,265,000 | -50.5% | 10,833 | 0.0% | 0.01% | -50.0% |
| Q1 2015 | $2,558,000 | +24.8% | 10,833 | 0.0% | 0.01% | +25.0% |
| Q4 2014 | $2,050,000 | – | 10,833 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |